Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 2.015
Filtrar
1.
Surg Endosc ; 2024 Sep 16.
Artículo en Inglés | MEDLINE | ID: mdl-39285040

RESUMEN

BACKGROUND: Surgical specialists experience significant musculoskeletal strain as a consequence of their profession, a domain within the healthcare system often recognized for the pronounced impact of such issues. The aim of this study is to calculate the risk of presenting musculoskeletal injuries in surgeons after surgical practice. METHODS: Cross-sectional study carried out using an online form (12/2021-03/2022) aimed at members of the Spanish Association of Surgeons. Demographic variables on physical and professional activity were recorded, as well as musculoskeletal pain (MSP) associated with surgical activity. Univariate and multivariate analysis were conducted to identify risk factors associated with the development of MSP based on personalized surgical activity. To achieve this, a risk algorithm was computed and an online machine learning calculator was created to predict them. Physiotherapeutic recommendations were generated to address and alleviate each MSP. RESULTS: A total of 651 surgeons (112 trainees, 539 specialists). 90.6% reported MSP related to surgical practice, 60% needed any therapeutic measure and 11.7% required a medical leave. In the long term, MSP was most common in the cervical and lumbar regions (52.4, 58.5%, respectively). Statistically significant risk factors (OR CI 95%) were for trunk pain, long interventions without breaks (3.02, 1.65-5.54). Obesity, indicated by BMI, to lumbar pain (4.36, 1.84-12.1), while an inappropriate laparoscopic screen location was associated with cervical and trunk pain (1.95, 1.28-2.98 and 2.16, 1.37-3.44, respectively). A predictive model and an online calculator were developed to assess MSP risk. Furthermore, a need for enhanced ergonomics training was identified by 89.6% of surgeons. CONCLUSIONS: The prevalence of MSP among surgeons is a prevalent but often overlooked health concern. Implementing a risk calculator could enable tailored prevention strategies, addressing modifiable factors like ergonomics.

2.
Front Public Health ; 12: 1416796, 2024.
Artículo en Inglés | MEDLINE | ID: mdl-39296844

RESUMEN

Objective: To evaluate the association between musculoskeletal pain and incident sarcopenia and further explore the mediating effect of depressive symptoms among middle-aged and older Chinese adults. Methods: Using the data from the China Health and Retirement Longitudinal Study 2011 and 2015, we included 12,788 participants in the cross-sectional analysis and 8,322 for the longitudinal analysis. Musculoskeletal pains located in the neck, back, waist, shoulder, arm, wrist, leg, knee, and ankle were self-reported at baseline and follow-up. The diagnosis criteria of sarcopenia was based on the Asian Working Group for Sarcopenia 2019. Multivariable logistic regression models were used to evaluate the association between musculoskeletal pain, and the Karlson-Holm-Breen (KHB) method was used to explore the mediating effect of depressive symptoms. Results: Over the 4-year follow-up, 445 participants were identified with incident sarcopenia. In the longitudinal analysis, participants with baseline musculoskeletal pain (adjusted odds ratio (OR): 1.37, 95% confidence interval (CI): 1.07-1.76), persistent musculoskeletal pain (OR:1.68, 95%CI: 1.28-2.24), and persistent waist pain (OR:1.46, 95%CI: 1.04-2.03) were significantly associated with increased the risk of incident sarcopenia. Furthermore, depressive symptoms were found to partially mediate the association between musculoskeletal pain and incident sarcopenia. Conclusion: Persistent musculoskeletal pain, especially in waist area, was positively associated with a higher risk of sarcopenia among the middle-aged and older Chinese. Depressive symptoms played a partial mediating role in this association.


Asunto(s)
Depresión , Dolor Musculoesquelético , Sarcopenia , Humanos , Masculino , Femenino , Sarcopenia/epidemiología , China/epidemiología , Depresión/epidemiología , Persona de Mediana Edad , Dolor Musculoesquelético/epidemiología , Estudios Transversales , Estudios Longitudinales , Anciano , Factores de Riesgo , Incidencia
3.
Narra J ; 4(2): e747, 2024 08.
Artículo en Inglés | MEDLINE | ID: mdl-39280295

RESUMEN

Musculoskeletal pain is one of the common symptoms of menopause syndrome throughout the world. Estradiol is the most potent and abundant derivative of estrogen and is associated with musculoskeletal pain, stiffness, and depressed mood during the menopausal transition. C-telopeptide is a molecule released during osteoclastic bone resorption and degradation of type I collagen, which is reported to have higher levels in individuals with musculoskeletal pain. An observational analytical study with a cross-sectional design was used in this research. Estradiol and C-telopeptide levels were measured in this study using enzyme-linked immunosorbent assay (ELISA). Musculoskeletal pain was assessed using the Nordic Musculoskeletal Questionnaire (NMQ) and the Menopause Quality of Life Questionnaire (MENQOL). Musculoskeletal pain was determined if the participant answered "yes" on questions number 12, 14 and 25 on the MENQOL. Data analysis was performed using the independent Student t-test for normally distributed data and the Mann-Whitney test for non-normally distributed data. A correlation test was performed using the Pearson correlation test for normally distributed data and the Spearman correlation test for non-normally distributed data. The results showed a non-significant relationship between estradiol and C-telopeptide levels with musculoskeletal pain assessed using the NMQ or MENQOL questionnaires. The correlation test also showed no correlation between estradiol and C-telopeptide levels in women with and without musculoskeletal pain.


Asunto(s)
Colágeno Tipo I , Estradiol , Menopausia , Dolor Musculoesquelético , Péptidos , Calidad de Vida , Humanos , Femenino , Estradiol/sangre , Dolor Musculoesquelético/sangre , Estudios Transversales , Persona de Mediana Edad , Menopausia/sangre , Colágeno Tipo I/sangre , Péptidos/sangre , Encuestas y Cuestionarios , Ensayo de Inmunoadsorción Enzimática
4.
Complement Ther Clin Pract ; 57: 101908, 2024 Sep 15.
Artículo en Inglés | MEDLINE | ID: mdl-39293126

RESUMEN

BACKGROUND: Opioid abuse and mortality are ravaging American society, highlighting the need to find alternative effective analgesics with fewer side effects. FDA-approved topical analgesics, including non-steroidal anti-inflammatory drugs (NSAIDs), are commonly used to treat musculoskeletal pain but can cause adverse effects. Natural compounds, including essential oils, are potential therapeutic alternatives for managing musculoskeletal pain. If these compounds can provide comparable analgesia to FDA-approved products, it will increase the available options for people with pain, improving quality of life with minimal morbidity and mortality. OBJECTIVE: This study assesses the effectiveness and onset of action of Bonipar, a topical analgesic formulated with camphor, methyl salicylate, and oils of coconut, eucalyptus, nutmeg, and rosemary, in managing musculoskeletal pain compared to 1.5 % diclofenac solution, an FDA-approved topical non-steroidal anti-inflammatory drug. METHODS: One hundred sixty-four adult patients with localized musculoskeletal pain were randomly assigned to twice-daily applications of either Bonipar or Diclofenac for one week. The primary outcome measure was a 50 % reduction in pain after one week. Secondary outcomes included the change in pain from baseline and onset of action, defined as the first reduction in pain by 20 %. RESULTS: All patients completed the initial pain assessment to determine the onset of action. One-week data was available for 74 patients treated with diclofenac and 72 patients treated with Bonipar. Data for 18 patients were incomplete. The proportion of patients achieving a 50 % reduction in pain was statistically similar between the two groups. The success rates of achieving a 50 % pain reduction with Bonipar were found to be non-inferior to those treated with diclofenac. All follow-up time points showed roughly similar results between the groups. Regression models adjusted for age and sex revealed no significant effects on pain changes. Secondary analyses demonstrated no significant differences between the groups. DISCUSSION: The topical analgesic Bonipar demonstrates a comparable onset of action, with efficacy non-inferior to diclofenac in the management of musculoskeletal pain, while showing fewer adverse effects compared to diclofenac. These findings highlight the potential of Bonipar as a valuable alternative for the treatment of localized pain.

5.
J Sleep Res ; : e14329, 2024 Sep 17.
Artículo en Inglés | MEDLINE | ID: mdl-39289848

RESUMEN

Sleep disturbances exacerbate chronic pain, increase psychological load, and increase inflammation. Delayed onset muscle soreness (DOMS) mimics aspects of chronic pain, predominantly affecting peripheral pain mechanisms, while experimental sleep provocations have been shown to impact central pain mechanisms. This study aimed to combine a DOMS model with total sleep deprivation (TSD) to create a novel model affecting both peripheral and central pain mechanisms. A total of 30 healthy participants attended two sessions (baseline and follow-up) separated by 24 h of TSD and a home rating after 48 h. Assessments of interleukin 6 (IL-6) levels, sleep quality, pain catastrophising, affect, and symptoms of depression and anxiety were included in the baseline and follow-up sessions. Additionally, pressure pain and tolerance thresholds, temporal summation, and conditioned pain modulation (CPM) were assessed using cuff-pressure algometry in the baseline and follow-up sessions. DOMS was induced with eccentric calf raises during the baseline session followed by 24 h of TSD. At follow-up pain tolerance (p = 0.012) was significantly reduced, and CPM (p = 0.036) was significantly impaired compared to baseline. Psychological changes included decreases in pain catastrophising (p = 0.027), positive affect (p < 0.001), negative affect (p = 0.003), and anxiety (p = 0.012). Explorative regression models predicted 58% and 68% of DOMS pain intensity after 24 and 48 h, respectively, based on baseline body mass index, pain thresholds, psychological measures, and IL-6 (p < 0.01). Combining DOMS with 1 night of TSD induced pain hypersensitivity, impaired CPM, and altered psychological states. A combination of baseline inflammation, psychological measures, and pain sensitivity significantly predicted DOMS pain intensity after 24 and 48 h.

6.
Sports Health ; : 19417381241278263, 2024 Sep 19.
Artículo en Inglés | MEDLINE | ID: mdl-39297289

RESUMEN

CONTEXT: Pilates exercise is commonly used in the rehabilitation of individuals with musculoskeletal conditions, but dosing parameters for optimal outcomes are unclear. Large variations exist in Pilates-based protocols, and research related to specific dosing is sparse. OBJECTIVE: To identify optimal dose parameters of Pilates exercise when applied to the rehabilitation of musculoskeletal conditions. DATA SOURCES: English-language articles published up to February 2023, in the PubMed, Scopus, Science Direct, and Pedro databases. STUDY SELECTION: Articles where patients 20-60 years old with musculoskeletal conditions received a Pilates-based exercise intervention and reported quantification of treatment dose. A total of 72 full-text articles were assessed, with 14 meeting inclusion criteria. STUDY DESIGN: Scoping review. DATA EXTRACTION: Two investigators (A.P.S., G.K.) independently identified all proposed Pilates-based protocols and outcome measures from the included studies. RESULTS: From the 1667 references initially found in 4 databases, 14 studies were included of which 13 were randomized controlled trials or quasi-experimental (612 patients) and 1 was a Cochrane review (19,642 patients). Eight studies were of high methodological quality. The most frequent musculoskeletal condition examined was chronic low back pain. Pilates dosage regarding total intervention duration ranged from 6 to 16 weeks, but the most frequent duration reported was 8 weeks and 2 to 3 sessions per week with sessions lasting 50 to 60 minutes. CONCLUSION: This review suggests that there are clinically relevant Pilates dosing parameters that result in improved outcomes for patients with musculoskeletal disorders.

7.
J Plast Reconstr Aesthet Surg ; 98: 214-229, 2024 Aug 25.
Artículo en Inglés | MEDLINE | ID: mdl-39288724

RESUMEN

INTRODUCTION: Ergonomics have significant implications for the surgical workforce that performs at the interface between human-operated equipment and patient anatomy to achieve clinical results. This systematic review evaluated the literature discussing ergonomics in plastic surgery to explore current knowledge, evaluate trends, and identify prime gaps for future study. METHODS: A systematic search strategy was developed by a licensed librarian and plastic surgeon to query all manuscripts evaluating ergonomics in plastic and reconstructive surgery. Two independent reviewers screened abstracts, evaluated full texts, and extracted data. RESULTS: Forty-six studies were ultimately included. The number of published studies increased significantly over time when evaluated by year (ρ = 0.660, p < 0.001), with 17 (36.9%) written since 2020. Studies more commonly discussed musculoskeletal pain/disorders (n = 23) compared to surgical instrumentation or technology (n = 18, p = 0.390), operative posture (n = 14, p = 0.041), surgical technique (n = 6, p = 0.002), peri-surgical practices (n = 5, p < 0.001), and surgeon physiology (n = 3, p < 0.001). Among the 19 studies, including interventions, approaches more frequently involved novel instrumentation or technology (n = 14, 73.4%) compared to peri-surgical practices (n = 3, 6.5%, p < 0.001) or operative posture (n = 2, 4.3%, p < 0.001). CONCLUSIONS: Ergonomics in plastic surgery has gained significant interest over time, with recent years representing a large proportion of published literature. Although most studies discuss musculoskeletal pain, the proportion of studies addressing posture and surgical practices are comparatively underrepresented, suggesting an opportunity for future intervention.

8.
Artículo en Inglés | MEDLINE | ID: mdl-39302094

RESUMEN

PURPOSE: Virtual reality-based therapy (VRBT) may be an effective physical therapy complement employed in the rehabilitation of patients with anterior cruciate ligament (ACL) injury. This study aims to assess the effectiveness of VRBT in improving pain, knee function, strength, proprioception, flexion range of motion (ROM), and dynamic balance after ACL injury. METHODS: We conducted this systematic review with meta-analysis following PRISMA criteria. Since inception to June 2024, we searched in PubMed Medline, WOS, SCOPUS, CINAHL and PEDro without publication date and language restrictions. Randomised controlled trials (RCTs), comprising only patients with ACL injury, that assess the effectiveness of VRBT compared to classical interventions on the outcomes of interest were included. PEDro scale was employed to analyze the methodological quality of the RCTs included. Cohen's standardised mean difference (SMD) and its 95% confidence interval (95% CI) was used to calculate the pooled effect in meta-analyses. RESULTS: Nine RCTs, providing data from 330 participants (26.96 ± 3.11 years, 85% males) were included. The RCTs included showed good methodological quality (PEDro scale = 6.88 points), being, performance and detection biases, the most common biases reported. Meta-analyses showed that VRBT was more effective than classical interventions in reducing pain (SMD = -1.15; 95% CI -1.85 to -0.45; p = 0.001; I2 = 0%), and increasing knee function (SMD = 1.71; 95% CI 0.93 to 2.5; p < 0.001; I2 = 0%), strength (SMD = 0.82; 95% CI 0.4-1.23; p < 0.001; I2 = 0%) and flexion ROM (SMD = 0.7; 95% CI 0.37-1.01; p < 0.001; I2 = 0%). Additionally, VRBT improved postero-medial (SMD = 0.46; 95% CI 0.01-0.9; p = 0.045; I2 = 15.1%) and postero-lateral CoP excursion (SMD = 0.75; 95% CI 0.3-1.21; p = 0.001; I2 = 0%), being effective in improving dynamic balance. CONCLUSION: VRBT is an effective physical therapy complement to be included in the ACL's rehabilitation programmes due to reduces pain and increases knee function, strength, ROM and dynamic balance after ACL injury. LEVEL OF EVIDENCE: Level II evidence.

9.
Pain Manag Nurs ; 2024 Sep 13.
Artículo en Inglés | MEDLINE | ID: mdl-39277454

RESUMEN

PURPOSE: To determine work-related musculoskeletal pain (MSP) among 105 operating room nurses (ORNs) and its effect on their routine work. DESIGN: Multicenter cross-sectional design. METHODS: This study was conducted with 105 nurses working in operating rooms of five different hospitals between December 15, 2021, and February 15, 2022. Data were collected using the "Nordic Musculoskeletal Questionnaire." SPSS 22.0 was used for data analysis, and a significance level of p < .05 was established. RESULTS: Among the nurses, 75.2% were female, 78.1% had undergraduate education, and 59% worked >40 hours/week. In the previous 12 months, 69.5% of ORNs experienced lower back pain; 68.6%, neck pain; and 61.9%, back pain. The duration spent working as a scrub nurse increased the possibility of experiencing pain in the hands, wrists, back, shoulders, and lower back region (p < .05), and women had an increased risk of lower back and back pain (p < .05). Neck, lower back, back, wrist, and hand pain increased the risk of being unable to perform daily tasks (p < .05). CONCLUSIONS: Extended work hours as a scrub nurse increase the risk of MSP, including lower back region, neck, and back pain among ORNs. Women have a higher risk of lower back and back pain. Addressing musculoskeletal issues in this profession is crucial. CLINICAL IMPLICATIONS: Addressing musculoskeletal discomfort is vital because of its impact on nurses' job performance and potential patient harm. Providing ergonomic equipment, training nurses on musculoskeletal health, and raising awareness can help. It is also important to encourage regular breaks.

10.
Emerg Med Australas ; 2024 Sep 13.
Artículo en Inglés | MEDLINE | ID: mdl-39268673

RESUMEN

OBJECTIVES: Low back pain was the sixth most common reason for an ED visit in 2022-2023 in Australia, one-third of these patients were subsequently admitted to hospital. Therefore, we have assessed whether some patients could be diverted to alternate clinical pathways, via admission to a virtual hospital (rpavirtual), and be cared for remotely in their own homes. METHODS: Ethics approval was granted for protocols X21-0278 & 2021/ETH10967 and X21-0094 & 2021/ETH00591. We conducted a mixed-method process evaluation, using the RE-AIM framework (reach, effectiveness, adoption, implementation and maintenance) to answer key questions regarding the Back@Home model of care. RESULTS: This preliminary evaluation describes a cohort of the first 50 patients who received care between 13 February and 31 July 2023. The service had high levels of reach and adoption, very low levels of ED representation, and no AEs. Virtual care cost a median of AU$2215 (interquartile range = AU$1724-AU$2855) per admission. Patients admitted virtually had the same high satisfaction with care as traditionally admitted patients and reported less pain and better physical function. CONCLUSIONS: Preliminary findings suggest that this model of care is a safe, acceptable, and feasible alternative to hospitalisation for non-serious low back pain, in a select cohort of patients meeting inclusion criteria. Further data collection will inform whether Back@Home has had an impact on length of stay or traditional admission rates.

11.
Artículo en Inglés | MEDLINE | ID: mdl-39218242

RESUMEN

OBJECTIVE: To determine the prevalence of spinal segmental sensitization (SSS) syndrome, a regional pain disorder, among patients visiting physical medicine and rehabilitation centers (PM&RCs) for chronic musculoskeletal pain (CMSP). DESIGN: An observational descriptive cross-sectional study conducted from March to July 2023. SETTING: Seven PM&RCs from five cities, representing three care systems: social security (SS), Ministry of Health (MH), and private practice (PP). PARTICIPANTS: All patients, regardless of age, attending a physiatry consultation for CMSP for the first time and who provided informed consent to participate were included. Non-probabilistic sampling was employed. INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURE: We estimated the overall prevalence of SSS syndrome as a percentage among patients with CMSP, stratified by healthcare institution, sex, age, and occupation type. We also recorded the spinal segments involved and any concomitant painful disorders (CPDs). SSS syndrome was diagnosed using standardized criteria. RESULTS: Of the eligible participants, 319 with CMSP were enrolled; 73.4% were female, and the median age of participants was 56.9 (range: 13-89) years. The overall prevalence of SSS syndrome was 53.3%. Of these, 69.1%, 42.2%, and 13.8% were in the SS, MH, and PP systems, respectively. The most affected were female participants (56.4%), those aged 50-64 years (60.4%), and those with active jobs (58.8%). Most commonly, the lumbosacral and lumbar segments were affected, followed by the lower and middle cervical levels. Spine pathologies were the most common CPDs. CONCLUSION: The prevalence of SSS syndrome was high among patients who visited PM&RCs for CMSP and varied according to the care system. Further research on SSS syndrome is warranted to relieve the burden it poses on patients with CMSP and ensure proper diagnosis in clinical practice.

12.
Artículo en Chino | MEDLINE | ID: mdl-39223041

RESUMEN

Objective: To explore the risk factors of neck work-related musculoskeletal disorders (WMSDs) among automobile manufacturing enterprise workers, and construct the risk prediction model. Methods: In May 2022, a cluster convenience sampling method was used to selet all front-line workers from an automobile manufacturing factory in Xiangyang City as the research objects. And a questionnaire survey was conducted using the modified Musculoskeletal Disorders Questionnaire to analyze the occurrence and exposure to risk factors of neck WMSDs. Logistic regression was used to analyze the influencing factors of workers' neck WMSDs symptoms, and Nomogram column charts was used to construct the risk prediction model. The accuracy of the model was evaluated by the receiver operating characteristic (ROC) curve, the Bootstrap resampling method was used to verify the model, Hosmer-Lemeshow goodness of fit test was used to evaluate the model, and the Calibration curve was drawn. Results: A total of 1783 workers were surveyed, and the incidence of neck WMSDs symptoms was 24.8% (442/1783). Univariate logistic regression showed that age, female, smoking, working in uncomfortable postures, repetitive head movement, feeling constantly stressed at work, and completing conflicting tasks in work could increase the risk of neck WMSDs symptoms in automobile manufacturing enterprise workers (OR=1.37, 95%CI: 1.16-1.62; OR=2.85, 95%CI: 1.56-5.20; OR=1.50, 95%CI: 1.18-1.91; OR=1.18, 95%CI: 1.02-1.37; OR=1.34, 95%CI: 1.04-1.72; OR=1.62, 95%CI: 1.21-2.17; OR=1.48, 95%CI: 1.13-1.92; P<0.05). While adequate rest time could reduce the risk of neck WMSDs symptoms (OR=0.56, 95%CI: 0.52-0.86, P<0.05). The risk prediction model of neck WMSDs of workers in automobile manutacturing factory had good prediction efficiency, and the area under the ROC curve was 0.72 (95%CI: 0.70-0.75, P<0.001) . Conclusion: The occurrence of neck WMSDs symptoms of workers in automobile manufacturing factory is relatively high. The risk prediction model constructed in this study can play a certain auxiliary role in predicting neck WMSDs symptoms of workers in automobile manufacturing enterprise workers.


Asunto(s)
Automóviles , Enfermedades Musculoesqueléticas , Enfermedades Profesionales , Humanos , Femenino , Enfermedades Musculoesqueléticas/epidemiología , Enfermedades Musculoesqueléticas/etiología , Masculino , Encuestas y Cuestionarios , Factores de Riesgo , Enfermedades Profesionales/epidemiología , Adulto , Modelos Logísticos , Cuello , Industria Manufacturera , Persona de Mediana Edad , Curva ROC
13.
Telemed J E Health ; 2024 Sep 11.
Artículo en Inglés | MEDLINE | ID: mdl-39258762

RESUMEN

Background: Virtual complementary and integrative health (CIH) therapy availability increased during the COVID-19 pandemic, but little is known about effectiveness. We examined the perceived effectiveness of in-person and virtual CIH therapies for patients with chronic musculoskeletal pain who recently started using CIH therapies. Methods: The sample included Veterans (n = 1,091) with chronic musculoskeletal pain, identified in the Veterans Health Administration's electronic health record based on initiation of CIH therapy use, who responded to VA's Patient Complementary and Integrative Health Therapy Experience Survey during March, 2021, to August, 2022. Using multivariable models with self-guided virtual (apps or videos) delivery as the reference, we compared patient-reported outcomes (pain, mental health, fatigue, and general well-being) associated with any yoga, Tai Chi/Qigong, or meditation use delivered: (1) only in-person, (2) only virtually with a live provider, (3) only virtually self-guided, (4) virtually self-guided + virtually provider-guided, or (5) hybrid in-person + virtual (self-or provider-guided). Results: Under 10% of Veterans reported only in-person use; 54% used only virtual formats and 36% a hybrid of in-person and virtual. Forty-one percent reported improvement in general well-being, 40.6% in mental health, 37.1% in pain, and 22.7% in fatigue. Compared with Veterans using only self-guided virtual CIH therapies, Veterans using only in-person therapies were more likely to report improvement in fatigue (odds ratio [OR]: 1.8, confidence interval [CI]: 1.1-3.1) and general well-being (OR: 1.7, CI: 1.0-2.6). Conclusions: Many patients perceived health improvements from CIH therapies, with in-person users reporting more improvement in fatigue and well-being than those using virtual sessions and similar improvements in pain and mental health for in-person and hybrid users.

14.
BMC Musculoskelet Disord ; 25(1): 698, 2024 Sep 02.
Artículo en Inglés | MEDLINE | ID: mdl-39223563

RESUMEN

INTRODUCTION: Conservative treatments such as physical therapies are usually the most indicated for the management of musculoskeletal pain; therefore, a detailed description of interventions enables the reproducibility of interventions in clinical practice and future research. The objective of this study is to evaluate the description of physical interventions for musculoskeletal pain in children and adolescents. METHODS: We considered randomized controlled trials that included children and adolescents between 4 and 19 years old with acute or chronic/persistent musculoskeletal pain. We included physical therapies related to all types of physical modalities aimed at reducing the intensity of pain or disability in children and adolescents with musculoskeletal pain. The description of interventions was assessed using the Template for Intervention Description and Replication (TIDieR) checklist. We performed electronic searches in the following databases: CENTRAL, MEDLINE, EMBASE, CINAHL, PsyINFO and PEDro up to April 2024. The description of physical interventions was presented using frequencies, percentages and 95% confidence intervals (CIs) of the TIDieR checklist items described in each study. We also calculated the total TIDieR score for each study and presented these data as mean and standard deviation. RESULTS: We included 17 randomized controlled trials. The description measured through the TIDieR checklist scored an average of 11 (5.2) points out of 24. The item of the TIDieR that was most described was item 1 (brief name) and most absent was item 10 (modifications). CONCLUSION: The descriptions of physical interventions for the treatment of musculoskeletal pain in children and adolescents are partially described, indicating the need for strategies to improve the quality of description to enable true clinical reproducibility.


Asunto(s)
Dolor Musculoesquelético , Ensayos Clínicos Controlados Aleatorios como Asunto , Humanos , Adolescente , Niño , Dolor Musculoesquelético/terapia , Dolor Musculoesquelético/diagnóstico , Ensayos Clínicos Controlados Aleatorios como Asunto/métodos , Reproducibilidad de los Resultados , Modalidades de Fisioterapia , Dimensión del Dolor/métodos , Preescolar , Adulto Joven , Resultado del Tratamiento , Manejo del Dolor/métodos , Lista de Verificación
15.
Front Public Health ; 12: 1422659, 2024.
Artículo en Inglés | MEDLINE | ID: mdl-39257944

RESUMEN

Objectives: Musculoskeletal pain after COVID-19 infection remains a concerning long-term complication of COVID-19. Here, our study aimed to investigate the prevalence of musculoskeletal pain associated with COVID-19 (MSPC) and healthcare-seeking behaviors, as well as the associating factors. Methods: A cross-sectional survey was conducted using convenience sampling and distributed to participants anonymously through the online platform Credamo. Demographic and characteristic data of the participants were collected and analyzed. Logistic regression analysis was employed to investigate potential factors associated with MSPC and healthcare-seeking tendencies. Results: A total of 1,510 participants responded to the survey, with 42.6% (643 individuals) exhibiting MSPC. Higher education level and a greater number of concomitant symptoms were significant risk factors for MSPC, while longer exercise duration and higher PSS-10 scores were protective factors. Additionally, higher income level, frequency and severity of pain, and greater PSS-10 scores increased healthcare-seeking intention. Conclusion: A significant proportion of individuals experience MSPC. Education level and concomitant symptoms were risk factors for MSPC, while exercise duration and PSS-10 score were potential protective factors. Income level, frequency and severity of pain, and PSS-10 score are significantly related to the willingness to seek medical treatment for MSPC.


Asunto(s)
COVID-19 , Dolor Musculoesquelético , Aceptación de la Atención de Salud , Humanos , Estudios Transversales , COVID-19/epidemiología , Masculino , Femenino , Adulto , Persona de Mediana Edad , Dolor Musculoesquelético/epidemiología , Factores de Riesgo , Prevalencia , Aceptación de la Atención de Salud/estadística & datos numéricos , Encuestas y Cuestionarios , SARS-CoV-2 , Anciano , Adulto Joven
16.
eNeuro ; 11(8)2024 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-39111835

RESUMEN

Animal studies consistently demonstrate that testosterone is protective against pain in multiple models, including an animal model of activity-induced muscle pain. In this model, females develop widespread muscle hyperalgesia, and reducing testosterone levels in males results in widespread muscle hyperalgesia. Widespread pain is believed to be mediated by changes in the central nervous system, including the rostral ventromedial medulla (RVM). The enzyme that converts testosterone to estradiol, aromatase, is highly expressed in the RVM. Therefore, we hypothesized that testosterone is converted by aromatase to estradiol locally in the RVM to prevent development of widespread muscle hyperalgesia in male mice. This was tested through pharmacological inhibition of estrogen receptors (ERs), aromatase, or ER-α in the RVM which resulted in contralateral hyperalgesia in male mice (C57BL/6J). ER inhibition in the RVM had no effect on hyperalgesia in female mice. As prior studies show modulation of estradiol signaling alters GABA receptor and transporter expression, we examined if removal of testosterone in males would decrease mRNA expression of GABA receptor subunits and vesicular GABA transporter (VGAT). However, there were no differences in mRNA expression of GABA receptor subunits of VGAT between gonadectomized and sham control males. Lastly, we used RNAscope to determine expression of ER-α in the RVM and show expression in inhibitory (VGAT+), serotonergic (tryptophan hydroxylase 2+), and µ-opioid receptor expressing (MOR+) cells. In conclusion, testosterone protects males from development of widespread hyperalgesia through aromatization to estradiol and activation of ER-α which is widely expressed in multiple cell types in the RVM.


Asunto(s)
Estradiol , Hiperalgesia , Bulbo Raquídeo , Ratones Endogámicos C57BL , Mialgia , Animales , Masculino , Estradiol/farmacología , Bulbo Raquídeo/metabolismo , Bulbo Raquídeo/efectos de los fármacos , Hiperalgesia/metabolismo , Ratones , Femenino , Mialgia/metabolismo , Receptor alfa de Estrógeno/metabolismo , Aromatasa/metabolismo , Testosterona/farmacología , Inhibidores de la Aromatasa/farmacología
17.
JMIR Mhealth Uhealth ; 12: e55625, 2024 Aug 14.
Artículo en Inglés | MEDLINE | ID: mdl-39141913

RESUMEN

BACKGROUND: Population studies show that musculoskeletal conditions are a leading contributor to the total burden of healthy life lost, second only to cancer and with a similar burden to cardiovascular disease. Prioritizing the delivery of effective treatments is necessary, and with the ubiquity of consumer smart devices, the use of digital health interventions is increasing. Messaging is popular and easy to use and has been studied for a range of health-related uses, including health promotion, encouragement of behavior change, and monitoring of disease progression. It may have a useful role to play in the management and self-management of musculoskeletal conditions. OBJECTIVE: Previous reviews on the use of messaging for people with musculoskeletal conditions have focused on synthesizing evidence of effectiveness from randomized controlled trials. In this review, our objective was to map the musculoskeletal messaging literature more broadly to identify information that may inform the design of future messaging interventions and summarize the current evidence of efficacy, effectiveness, and economics. METHODS: Following a prepublished protocol developed using the Joanna Briggs Institute Manual for Evidence Synthesis, we conducted a comprehensive scoping review of the literature (2010-2022; sources: PubMed, CINAHL, Embase, and PsycINFO) related to SMS text messaging and app-based messaging for people with musculoskeletal conditions. We described our findings using tables, plots, and a narrative summary. RESULTS: We identified a total of 8328 papers for screening, of which 50 (0.6%) were included in this review (3/50, 6% previous reviews and 47/50, 94% papers describing 40 primary studies). Rheumatic diseases accounted for the largest proportion of the included primary studies (19/40, 48%), followed by studies on multiple musculoskeletal conditions or pain sites (10/40, 25%), back pain (9/40, 23%), neck pain (1/40, 3%), and "other" (1/40, 3%). Most studies (33/40, 83%) described interventions intended to promote positive behavior change, typically by encouraging increased physical activity and exercise. The studies evaluated a range of outcomes, including pain, function, quality of life, and medication adherence. Overall, the results either favored messaging interventions or had equivocal outcomes. While the theoretical underpinnings of the interventions were generally well described, only 4% (2/47) of the papers provided comprehensive descriptions of the messaging intervention design and development process. We found no relevant economic evaluations. CONCLUSIONS: Messaging has been used for the care and self-management of a range of musculoskeletal conditions with generally favorable outcomes reported. However, with few exceptions, design considerations are poorly described in the literature. Further work is needed to understand and disseminate information about messaging content and message delivery characteristics, such as timing and frequency specifically for people with musculoskeletal conditions. Similarly, further work is needed to understand the economic effects of messaging and practical considerations related to implementation and sustainability. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): RR2-10.1136/bmjopen-2021-048964.


Asunto(s)
Dolor Musculoesquelético , Envío de Mensajes de Texto , Humanos , Envío de Mensajes de Texto/estadística & datos numéricos , Envío de Mensajes de Texto/instrumentación , Envío de Mensajes de Texto/normas , Dolor Musculoesquelético/terapia
18.
Musculoskelet Sci Pract ; 73: 103162, 2024 10.
Artículo en Inglés | MEDLINE | ID: mdl-39167860

RESUMEN

BACKGROUND: Subjective pain intensity can be measured using instruments like the Faces Pain Scale-Revised (FPS-R), Verbal Rating Scale (VRS), Numerical Pain Rating Scale (NPRS), and Visual Analogue Scale (VAS). However, information on physiotherapists' and patients' knowledge and preference for these tools is scarce. OBJECTIVE: We investigated the knowledge and preference of physiotherapists and participants with musculoskeletal pain (MP) regarding the pain intensity measurement scales. METHODS: This cross-sectional study consisted of physiotherapists and participants with MP. Physiotherapists were recruited via social media for an online open survey, gathering sociodemographic, professional data, and their knowledge and preferences for pain intensity scales. Participants over 18 with MP, participated in interviews focusing on their familiarity and preferences for pain intensity scales. Data was analyzed descriptively, and Chi-squared test evaluated scale preferences. RESULTS: We included 352 physiotherapists (mean experience = 10.5 years) and 94 participants with MP. Of the physiotherapists, 94.3% were familiar with pain scales, but 30.4% struggled to differentiate them. The NPRS was the most used (56.3%) and preferred scale (52.4%). Among participants with MP, unfamiliarity was noted with all scales. After instruction, 46% preferred FPS-R, with preference varying by income and education levels (p < 0.001). CONCLUSION: We found a knowledge gap among physiotherapists in identifying pain intensity scales, with a preference for the NPRS among those familiar with the scales. Participants with MP had limited familiarity with these scales. After instructions, these participants preferred the FPS-R, particularly those with lower income and education levels.


Asunto(s)
Dolor Musculoesquelético , Dimensión del Dolor , Fisioterapeutas , Humanos , Estudios Transversales , Femenino , Masculino , Dolor Musculoesquelético/psicología , Dolor Musculoesquelético/terapia , Fisioterapeutas/psicología , Adulto , Persona de Mediana Edad , Encuestas y Cuestionarios , Conocimientos, Actitudes y Práctica en Salud
19.
J Med Internet Res ; 26: e48787, 2024 Aug 19.
Artículo en Inglés | MEDLINE | ID: mdl-39159449

RESUMEN

BACKGROUND: Virtual reality (VR) in different immersive conditions has been increasingly used as a nonpharmacological method for managing chronic musculoskeletal pain. OBJECTIVE: We aimed to assess the effectiveness of VR-assisted active training versus conventional exercise or physiotherapy in chronic musculoskeletal pain and to analyze the effects of immersive versus nonimmersive VR on pain outcomes. METHODS: This systematic review of randomized control trials (RCTs) searched PubMed, Scopus, and Web of Science databases from inception to June 9, 2024. RCTs comparing adults with chronic musculoskeletal pain receiving VR-assisted training were included. The primary outcome was pain intensity; secondary outcomes included functional disability and kinesiophobia. Available data were pooled in a meta-analysis. Studies were graded using the Cochrane Risk-of-Bias Tool version 2. RESULTS: In total, 28 RCTs including 1114 participants with some concerns for a high risk of bias were identified, and 25 RCTs were included in the meta-analysis. In low back pain, short-term outcomes measured post intervention showed that nonimmersive VR is effective in reducing pain (standardized mean difference [SMD] -1.79, 95% CI -2.72 to -0.87; P<.001), improving disability (SMD -0.44, 95% CI -0.72 to -0.16; P=.002), and kinesiophobia (SMD -2.94, 95% CI -5.20 to -0.68; P=.01). Intermediate-term outcomes measured at 6 months also showed that nonimmersive VR is effective in reducing pain (SMD -8.15, 95% CI -15.29 to -1.01; P=.03), and kinesiophobia (SMD -4.28, 95% CI -8.12 to -0.44; P=.03) compared to conventional active training. For neck pain, immersive VR reduced pain intensity (SMD -0.55, 95% CI -1.02 to -0.08; P=.02) but not disability and kinesiophobia in the short term. No statistical significances were detected for knee pain or other pain regions at all time points. In addition, 2 (8%) studies had a high risk of bias. CONCLUSIONS: Both nonimmersive and immersive VR-assisted active training is effective in reducing back and neck pain symptoms. Our study findings suggest that VR is effective in alleviating chronic musculoskeletal pain. TRIAL REGISTRATION: PROSPERO CRD42022302912; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=302912.


Asunto(s)
Dolor Crónico , Dolor Musculoesquelético , Realidad Virtual , Humanos , Dolor Musculoesquelético/terapia , Dolor Musculoesquelético/psicología , Dolor Crónico/terapia , Dolor Crónico/psicología , Ensayos Clínicos Controlados Aleatorios como Asunto , Terapia de Exposición Mediante Realidad Virtual/métodos , Adulto , Terapia por Ejercicio/métodos , Dolor de la Región Lumbar/terapia , Dolor de la Región Lumbar/psicología , Masculino , Femenino
20.
Sleep Med ; 122: 198-207, 2024 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-39186913

RESUMEN

OBJECTIVES: Prolonged sitting is associated with an increased risk of musculoskeletal pain, especially in nightshift workers. However, research investigating effects of breaking up sitting on musculoskeletal pain during nightshifts is lacking. This study evaluated effects of prolonged sitting or breaking up sitting with short bouts of light-intensity physical activity on pain in healthy adults during simulated nightshifts. METHODS: An in-laboratory randomised controlled trial was undertaken with 52 healthy adults completing five simulated nightshifts. Participants were randomised to prolonged sitting (Sit9; n = 26) or breaking up prolonged sitting (Break9; n = 26). Break9 group completed 3-min walking every 30 min during nightshifts, while Sit9 group remained seated. Musculoskeletal pain intensity and sensory/affective pain experiences were assessed. Linear mixed models examined pain within nights (pre-to post-shift) and across nights (pre-shift-night-1 to pre-shift-night-5). RESULTS: Musculoskeletal pain intensity increased within nights for both Sit9 (mean change [95%CI] points: 0.14 [0.05, 0.24]) and Break9 (0.09 [0.001, 0.19], but not across nights (Sit9: -0.13 [-0.33, 0.08]; Break9: 0.07 [-0.14, 0.29]). Sensory-pain experience improved across nights for Sit9 (-3.08 [-4.72, -1.45]), but not within nights (0.77 [-0.004, 1.55]). There was no change in affective-pain experience in either group. Between-group difference was observed favouring Sit9 for improving sensory-pain across nights (ß: 3.71 [1.42, 5.99]). No other between-group difference was observed. CONCLUSION: Both prolonged sitting and breaking up sitting were associated with a within-night increase in musculoskeletal pain intensity. Compared to prolonged sitting, breaking up sitting did not induce benefits on pain in healthy adults working simulated nightshifts. TRIAL REGISTRATION: ACTRN12619001516178.


Asunto(s)
Dolor Musculoesquelético , Sedestación , Humanos , Masculino , Femenino , Adulto , Ejercicio Físico/fisiología , Adulto Joven , Postura/fisiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA